Home > News

News

James Duncan Kelly & Kwok Wai Chiu v GE Healthcare Ltd [2009] EWHC 181 (Pat)11 February 2009Andrew Lykiardopoulos appeared as junior counsel for the Defendant, GE Healthcare. The trial, in December 2008, was about whether two research scientists were entitled to compensation under s.40 of the Patents Act 19977 for the benefit that GE Healthcare had gained from the patented inventions which the researchers had developed whilst they were employees. The […]
Zipher Ltd v Markem Systems Ltd, Markem Technologies Ltd [2009] EWCA Civ 4410 February 2009In January 2009 Adrian Speck appeared as junior counsel for the appellant and Richard Meade QC appeared as leading counsel for the respondents. The trial at first instance was a claim for infringement brought by Zipher against Markem in which Markem brought a counter claim for invalidity of a number of Zipher’s patents. Floyd J […]
Laboratorios Almirall SA -and- Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)23 January 2009Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other’s patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held […]
Virgin Atlantic Airways Ltd v Premium Aircraft Interiors Group Ltd and Premium Aircraft Interiors UK Ltd [2009] EWHC 2621 January 2009Richard Meade QC, Henry Ward and Jessie Bowhill appeared for the claimants, Virgin Atlantic, in the trial before Mr. Justice Lewison in November 2008. Virgin brought a claim against Premium Aircraft alleging that that Premium Aircraft Interiors, the manufacturer of its patented flat-bed seat (called ‘the UCS’), had manufactured other seats or kits for other […]
Actavis v Novartis [2009] EWHC 41 (Ch)16 January 2009The trial, held in July 2008, was about a European Patent for a sustained release formulation of a drug called fluvastatin, a type of statin which reduces blood cholesterol. Actavis sought to revoke the patent on the grounds of obviousness and insufficiency. Novartis did not defend the claims as granted but applied to amend. The […]